Cargando…

Line- and Point-Focused Extracorporeal Shock Wave Therapy for Achilles Tendinopathy: A Placebo-Controlled RCT Study

BACKGROUND: Extracorporeal shock wave therapy (ESWT) is a widely considered treatment option for Achilles tendinopathy. Line-focused ESWT is a novel technique treating a larger tendon area than point-focused ESWT. Monitoring capacities of clinical symptoms with ultrasound under ESWT treatment are un...

Descripción completa

Detalles Bibliográficos
Autores principales: Gatz, Matthias, Schweda, Sebastian, Betsch, Marcel, Dirrichs, Timm, de la Fuente, Matias, Reinhardt, Nina, Quack, Valentin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8404720/
https://www.ncbi.nlm.nih.gov/pubmed/33586526
http://dx.doi.org/10.1177/1941738121991791
_version_ 1783746219897520128
author Gatz, Matthias
Schweda, Sebastian
Betsch, Marcel
Dirrichs, Timm
de la Fuente, Matias
Reinhardt, Nina
Quack, Valentin
author_facet Gatz, Matthias
Schweda, Sebastian
Betsch, Marcel
Dirrichs, Timm
de la Fuente, Matias
Reinhardt, Nina
Quack, Valentin
author_sort Gatz, Matthias
collection PubMed
description BACKGROUND: Extracorporeal shock wave therapy (ESWT) is a widely considered treatment option for Achilles tendinopathy. Line-focused ESWT is a novel technique treating a larger tendon area than point-focused ESWT. Monitoring capacities of clinical symptoms with ultrasound under ESWT treatment are unknown. HYPOTHESIS: Point- and line-focused ESWT have a superior outcome than placebo ESWT. ESWT leads to morphological tendon changes detectable with ultrasound. STUDY DESIGN: Single-blinded placebo-controlled randomized contolled trial. LEVEL OF EVIDENCE: Level 1. METHODS: The study was conducted in 3 cohorts, namely ESWT point (n = 21), ESWT line (n = 24), and ESWT placebo (n = 21). Victorian Institute of Sports Assessment–Achilles (VISA-A) score was measured before the intervention (T0), after 6 weeks (T1), and after 24 weeks (T2). All cohorts performed daily physiotherapy for 24 weeks and received 4 sessions of point-focused, line-focused, or placebo ESWT in the first 6 weeks. Ultrasound was performed with B-mode, power Doppler, shear wave elastography (SWE) at T0 and T2 and with ultrasound tissue characterization (UTC) at T0, T1, and T2. Data were analyzed with a mixed analysis of variance and t test. RESULTS: There was a significant VISA-A improvement over time for all groups (P < 0.001). ESWT point had the strongest VISA-A score improvement +23 (ESWT line: +18; ESWT placebo: +15), but there was no significant interaction between time and any of the groups: F(4, 116) = 1.393; P = 0.24. UTC, power Doppler, and B-mode could not show significant alterations over time. SWE revealed a significant increase of elastic properties for ESWT point in the insertion (t = −3.113, P = 0.03) and midportion (t = −2.627, P = 0.02) over time. CONCLUSION: There is a significant VISA-A score improvement for all study groups without a statistically significant benefit for ESWT point or ESWT line compared with ESWT placebo. Tendon adaptation could only be detected with SWE for ESWT point. CLINICAL RELEVANCE: The present study could not detect any statistically relevant effect of ESWT compared to placebo. SWE is able to demonstrate tendon adaptation.
format Online
Article
Text
id pubmed-8404720
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-84047202021-09-02 Line- and Point-Focused Extracorporeal Shock Wave Therapy for Achilles Tendinopathy: A Placebo-Controlled RCT Study Gatz, Matthias Schweda, Sebastian Betsch, Marcel Dirrichs, Timm de la Fuente, Matias Reinhardt, Nina Quack, Valentin Sports Health Current Research BACKGROUND: Extracorporeal shock wave therapy (ESWT) is a widely considered treatment option for Achilles tendinopathy. Line-focused ESWT is a novel technique treating a larger tendon area than point-focused ESWT. Monitoring capacities of clinical symptoms with ultrasound under ESWT treatment are unknown. HYPOTHESIS: Point- and line-focused ESWT have a superior outcome than placebo ESWT. ESWT leads to morphological tendon changes detectable with ultrasound. STUDY DESIGN: Single-blinded placebo-controlled randomized contolled trial. LEVEL OF EVIDENCE: Level 1. METHODS: The study was conducted in 3 cohorts, namely ESWT point (n = 21), ESWT line (n = 24), and ESWT placebo (n = 21). Victorian Institute of Sports Assessment–Achilles (VISA-A) score was measured before the intervention (T0), after 6 weeks (T1), and after 24 weeks (T2). All cohorts performed daily physiotherapy for 24 weeks and received 4 sessions of point-focused, line-focused, or placebo ESWT in the first 6 weeks. Ultrasound was performed with B-mode, power Doppler, shear wave elastography (SWE) at T0 and T2 and with ultrasound tissue characterization (UTC) at T0, T1, and T2. Data were analyzed with a mixed analysis of variance and t test. RESULTS: There was a significant VISA-A improvement over time for all groups (P < 0.001). ESWT point had the strongest VISA-A score improvement +23 (ESWT line: +18; ESWT placebo: +15), but there was no significant interaction between time and any of the groups: F(4, 116) = 1.393; P = 0.24. UTC, power Doppler, and B-mode could not show significant alterations over time. SWE revealed a significant increase of elastic properties for ESWT point in the insertion (t = −3.113, P = 0.03) and midportion (t = −2.627, P = 0.02) over time. CONCLUSION: There is a significant VISA-A score improvement for all study groups without a statistically significant benefit for ESWT point or ESWT line compared with ESWT placebo. Tendon adaptation could only be detected with SWE for ESWT point. CLINICAL RELEVANCE: The present study could not detect any statistically relevant effect of ESWT compared to placebo. SWE is able to demonstrate tendon adaptation. SAGE Publications 2021-02-13 /pmc/articles/PMC8404720/ /pubmed/33586526 http://dx.doi.org/10.1177/1941738121991791 Text en © 2021 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 License (https://creativecommons.org/licenses/by-nc-nd/4.0/) which permits non-commercial use, reproduction and distribution of the work as published without adaptation or alteration, without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Current Research
Gatz, Matthias
Schweda, Sebastian
Betsch, Marcel
Dirrichs, Timm
de la Fuente, Matias
Reinhardt, Nina
Quack, Valentin
Line- and Point-Focused Extracorporeal Shock Wave Therapy for Achilles Tendinopathy: A Placebo-Controlled RCT Study
title Line- and Point-Focused Extracorporeal Shock Wave Therapy for Achilles Tendinopathy: A Placebo-Controlled RCT Study
title_full Line- and Point-Focused Extracorporeal Shock Wave Therapy for Achilles Tendinopathy: A Placebo-Controlled RCT Study
title_fullStr Line- and Point-Focused Extracorporeal Shock Wave Therapy for Achilles Tendinopathy: A Placebo-Controlled RCT Study
title_full_unstemmed Line- and Point-Focused Extracorporeal Shock Wave Therapy for Achilles Tendinopathy: A Placebo-Controlled RCT Study
title_short Line- and Point-Focused Extracorporeal Shock Wave Therapy for Achilles Tendinopathy: A Placebo-Controlled RCT Study
title_sort line- and point-focused extracorporeal shock wave therapy for achilles tendinopathy: a placebo-controlled rct study
topic Current Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8404720/
https://www.ncbi.nlm.nih.gov/pubmed/33586526
http://dx.doi.org/10.1177/1941738121991791
work_keys_str_mv AT gatzmatthias lineandpointfocusedextracorporealshockwavetherapyforachillestendinopathyaplacebocontrolledrctstudy
AT schwedasebastian lineandpointfocusedextracorporealshockwavetherapyforachillestendinopathyaplacebocontrolledrctstudy
AT betschmarcel lineandpointfocusedextracorporealshockwavetherapyforachillestendinopathyaplacebocontrolledrctstudy
AT dirrichstimm lineandpointfocusedextracorporealshockwavetherapyforachillestendinopathyaplacebocontrolledrctstudy
AT delafuentematias lineandpointfocusedextracorporealshockwavetherapyforachillestendinopathyaplacebocontrolledrctstudy
AT reinhardtnina lineandpointfocusedextracorporealshockwavetherapyforachillestendinopathyaplacebocontrolledrctstudy
AT quackvalentin lineandpointfocusedextracorporealshockwavetherapyforachillestendinopathyaplacebocontrolledrctstudy